São Paulo – A Saudi Arabian importer will join a B2B event the Brazilian Pharma Chemical and Pharma Inputs Association (Abiquifi) and the Brazilian Trade and Investment Promotion Agency (Apex-Brasil) will host on Tuesday (22) and Thursday (24) in São Paulo.
The event will take place in the Abiquifi stand at FCE Pharma,a pharma tech industry running from May 21 to 24 at São Paulo Expo. Importers from will Turkey, Iran and Chile will also attend.
Abiquifi executive secretary Norberto Prestes said the Saudi importer works in distribution. Saudi Arabia is a pharma distribution hub for Arab countries, according to Prestes.
He said Arab countries are a major market for medication and industry inputs. “They have a big population, and Brazil is in good diplomatic standing with Arab countries, and this makes doing business easier,” Prestes told ANBA.
Meetings have been scheduled with 15 Brazilian enterprises offering finished products and inputs which are affiliated with an Abiquifi/Apex-Brasil industry internationalization project.
Non-Brazilian buyers include both distributors and pharma manufacturers. The latter are often interested in partnering up with Brazilian industry players to get knowledge and explore new markets.
The ‘buyer project’ at FCE Pharma (past edition pictured above) is going into its fourth year. The B2B meetings will take place on the first and third day of the expo; on the second day, the importers will led on a tour of Brazilian manufacturers’ facilities.
The bringing of importers to Brazil is one of several actions under the Abiquifi/Apex-Brasil internationalization project. Activities also include exporter and would-be exporter group trips to other countries, international trade shows, training and market surveys.
The project comprises pharma inputs, human and animal medication and biotechnology.
As per Brazilian Ministry of Industry, Foreign Trade and Services numbers made public by Abiquifi, pharma/ pharma chemical exports from Brazil were up 5.8% last year to USD 1.75% billion, up from USD 1.6 million in 2016; medication made up USD 1 billion of sales, with inputs grossing USD 752 billion.
Translated by Gabriel Pomerancblum